Stock MANKIND MANKIND PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Mankind Pharma Limited

Equities

MANKIND

INE634S01028

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 07:43:49 2024-05-09 am EDT 		5-day change 1st Jan Change
2,171 INR -0.52% Intraday chart for Mankind Pharma Limited -8.17% +9.52%
May. 03 KKR, Novo Nordisk, Others Reportedly Bid for Healthium Buy CI
Apr. 26 Mankind Pharma Limited Receives Order from Office of Commissioner of Central Tax, Central Excise and Service Tax, Secunderabad GST Commissionerate GST Bhawan, Hyderabad CI

Business Summary

Mankind Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It has a portfolio of formulations in several therapeutic areas, such as anti-infectives, cardiovascular, gastrointestinal, vitamins/minerals/nutrients, respiratory, anti-diabetic, dermatology, gynecology, and pain/analgesics, among others. Its other therapeutic areas include urology, ophthalmology, antiparasitic, stomatological, antineoplastic/immunomodulator, hepatoprotective, anti-malarial, blood-related, hormones, antiviral, sex stimulants/rejuvenators, anti-tuberculosis, parenteral and vaccines. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others.

Number of employees: 18,468

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceuticals and Other related Products
100.0 %
77,816 100.0 % 87,494 100.0 % +12.44%

Sales per region

INR in Million2022Weight2023Weight Delta
India
96.6 %
75,947 97.6 % 84,470 96.6 % +11.22%
International
3.4 %
1,868 2.4 % 2,958 3.4 % +58.36%

Managers

Managers TitleAgeSince
Sheetal Arora CEO
 Chief Executive Officer 48 07-09-20
Ashutosh Dhawan DFI
 Director of Finance/CFO 55 16-06-16
Pradeep Chugh CMP
 Compliance Officer - 16-09-22
Pramod Gokhale CTO
 Chief Tech/Sci/R&D Officer - 10-05-13
Anil Kumar CTO
 Chief Tech/Sci/R&D Officer - 11-11-30
Chanakya Juneja CTO
 Chief Tech/Sci/R&D Officer - 19-11-14
Arjun Juneja COO
 Chief Operating Officer - 09-05-14
Rajeev Juneja BRD
 Director/Board Member 58 92-12-21
Ravi Kumar Agrawal IRC
 Investor Relations Contact - -
Akshay Bansal PRN
 Corporate Officer/Principal 50 -

Members of the board

Members of the board TitleAgeSince
Vivek Kalra BRD
 Director/Board Member 60 22-07-31
Vijaya Sampath BRD
 Director/Board Member 71 22-07-31
Surendra Lunia BRD
 Director/Board Member 61 15-02-18
Ramesh Chand Juneja FOU
 Founder 68 85-12-31
Rajeev Juneja BRD
 Director/Board Member 58 92-12-21
Sheetal Arora CEO
 Chief Executive Officer 48 07-09-20
Tilokchand Punamchand Ostwal BRD
 Director/Board Member 69 19-12-31
Bharat Anand BRD
 Director/Board Member 47 18-08-30
Arjun Juneja COO
 Chief Operating Officer - 09-05-14
Satish Kumar Sharma BRD
 Director/Board Member 50 16-09-22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 400,588,440 79,747,743 ( 19.91 %) 0 19.91 %

Shareholders

NameEquities%Valuation
Juneja Ramesh Family Trust
20.81 %
83,352,652 20.81 % 2 296 M ₹
Juneja Rajeev Family Trust
19.95 %
79,930,520 19.95 % 2 202 M ₹
Sheetal Prem Family Trust
15.42 %
61,755,635 15.42 % 1 701 M ₹
Capital Group Private Markets, Inc.
5.363 %
21,484,560 5.363 % 592 M ₹
Sheetal Arora
5.266 %
21,094,717 5.266 % 581 M ₹
Puja Juneja
3.446 %
13,805,242 3.446 % 380 M ₹
Poonam Juneja
2.636 %
10,557,626 2.636 % 291 M ₹
Arjun Juneja
2.635 %
10,555,591 2.635 % 291 M ₹
Beige Ltd.
2.043 %
8,185,333 2.043 % 225 M ₹
Ramesh Chand Juneja
1.711 %
6,855,990 1.711 % 189 M ₹

Company contact information

Mankind Pharma Ltd.

262, Okhla Industrial Estate Phase-III

110020, New Delhi

+91 11 4654 1111

http://www.mankindpharma.com
address Mankind Pharma Limited(MANKIND)

Group companies

NameCategory and Sector
PackTime Innovations Pvt Ltd.
Copmed Pharmaceuticals Pvt Ltd.

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Mankind Pharma Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
2,171 INR
Average target price
2,186 INR
Spread / Average Target
+0.70%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
MANKIND PHARMA LIMITED Stock Mankind Pharma Limited
+9.52% 10.48B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.36% 698B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.40% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.46% 328B
ABBVIE INC. Stock AbbVie Inc.
+3.50% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.34% 238B
NOVARTIS AG Stock Novartis AG
+6.68% 203B
ROCHE HOLDING AG Stock Roche Holding AG
-9.08% 198B
AMGEN INC. Stock Amgen Inc.
+8.62% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MANKIND Stock
  4. Company Mankind Pharma Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW